Australian
Pro-Lifers Lose Embryonic Research Battle
By Patrick Goodenough
CNSNews.com Pacific Rim Bureau Chief
December 06, 2002
Pacific
Rim Bureau (CNSNews.com) - After a long and divisive national
debate, Australia's Senate has passed legislation allowing
researchers to harvest human embryos for their stem cells
- and destroy them in the process.
Pro-life
Senators expressed sorrow at the outcome, which will give
scientists access to some 70,000 frozen embryos, created during
in-vitro fertilization (IVF) treatment but unwanted by their
parents.
Proponents
of embryonic stem cell research say the cells - the building
blocks of human skin, muscle, blood and tissue - could one
day provide treatments for a range of diseases.
But
for many pro-lifers the destruction of the early-stage human
life is intolerable whatever the potential future benefit,
as well as unnecessary, because "adult" cells from
alternative sources are available.
"I've
never been so disappointed as I am today," said Senator
Ron Boswell, a 20-year veteran of the Senate and member of
the National Party, the junior coalition partner in Prime
Minister John Howard's ruling coalition.
An
independent colleague who had also strongly opposed the bill,
Brian Harradine, said the result had prompted him to consider
seriously whether he ought to resign.
The
Senate voted 45-26 in favor of the Research Involving Embryos
Bill, with members permitted to a rare conscience vote on
the issue.
In
both the Senate and lower House of Representatives, the subject
divided major parties and resulted in unlikely alliances across
traditional liberal-conservative lines. Even the cabinet was
split.
Another
Senate pro-lifer, Guy Barnett, fought hard for the bill's
defeat despite the fact his father died of motor neurone disease
(also known as ALS or Lou Gehrig's disease), and he is himself
an insulin-dependent diabetic.
The
two illnesses are among those scientists say are the most
promising targets for future embryonic stem cell-based treatments.
With
his health history, Barnett said, "I had to think about
these issues very hard ... but the ends don't justify the
means and I cannot support the legislation."
Throughout
this year, senior Australian churchmen have come out in opposition
to embryonic research.
Reacting
to the vote, Roman Catholic Archbishop Philip Wilson said
parliament had "created for the first time in Australian
political and legal history a class of human life which is
statutorily expendable."
"Human
life now becomes a commercial commodity," he said. "Under
these laws, human life is for sale."
Wilson
pointed out that out of 1,851 submissions received by a Senate
committee, only 48 had supported the bill.
The
Anglican Archbishop of Sydney, Peter Jensen, called the decision
"dangerous and unethical."
Long
and acrimonious debate
Along
with the issue of terrorism, the controversial research has
been a dominant subject in Australian politics since last
April, when Howard agreed with premiers of the country's six
states and two territories that there should be uniform federal
legislation covering the work.
Howard
had himself been the subject of vigorous lobbying by advocates
and opponents, eventually coming out in cautious support of
the research.
During
the subsequent debate in the House of Representatives, lawmakers
heard the views of leading scientists on both sides - including
some prominent figures flown in from the U.S. to lend weight
to their locally-based colleagues' arguments.
The
campaign in favor of the research was spearheaded by an Australian
pioneer in reproductive technologies, Prof. Alan Trounson
He
and other advocates warned that Australia would lose scientists
to institutions abroad, and forfeit its position in the forefront
of the bio-technology field.
Trounson
ran into trouble, however, when he screened a video for lawmakers
that showed a crippled rat being able to walk again, supposedly
after treatment with embryonic stem cells.
After
opponents cried foul, the scientist later conceded that the
rat had actually been treated with germ cells from an aborted
fetus, not embryonic cells - treatment that would not have
been allowed under the bill anyway.
Meanwhile
those lobbying against the bill argued that the real aim of
researchers was not to find cures, but to get their hands
on embryos on which they could test drugs, study toxins' effects
and carry out genetic research.
The
bill's opponents also pointed out that, to date, only "adult"
stem cells derived from sources like bone marrow and placentas
- and therefore ethically uncontroversial - have succeeded
in therapeutic studies.
They
accused advocates like Trounson of giving patients false hope,
saying it was drug and biotech companies that would be the
true beneficiaries of the work, rather than those suffering
from diseases like Parkinson's.
The
bill eventually was passed in the House last September, at
the end of a 35-hour debate, by 99 votes to 33.
It
then moved to the Senate, where Boswell succeeded in holding
it up by having it referred to a committee for a two-month
inquiry.
Finally
this week, dozens of amendments were debated in marathon sittings,
including one calling for drugs and cosmetics tested on embryonic
stem cells to be labeled as such - which failed.
The
Senate then cut short debate and called a vote Thursday.
Howard
welcomed the outcome, saying he had no doubt "we've done
the right thing."
The
bill now returns to the House of Representatives for consideration
of minor amendments passed by the Senate, none of which are
expected to prevent final passage.
The
legislation is expected to take effect next year.
|